ArticleCancer drug resistance (Alhambra, Calif.)2021

EGFR/BRAF/MEK co-inhibition for EGFR-mutated lung adenocarcinoma patients with an acquired BRAF

Ran Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.